| Anti-IL-2 | dosage | Ig gamma-1 chain C region; Daclizumab; Humanized antiCD25; Zenapax (Hoffmann-La Roche Inc) |
| Basiliximab | Powder for solution | Ig gamma-1 chain C region; chimeric mouse-human antiCD25; Simulect (Novartis Pharmaceuticals) |
| Cyclosporine | Capsule (liquid-filled); Capsule (liquid-filled for emulsion); Solution (oral); Solution (IV infusion) | Gengraf; Neoral; Restasis; Sandimmune; Gengraf (Abbott labs); Neoral (Novartis); Restasis (Allergan Inc); Sandimmune (Novartis) |
| Daclizumab | Solution (IV) | Ig gamma-1 chain C region; Anti-IL-2; Humanized antiCD25; Zenapax (Hoffmann-La Roche Inc) |
| Efalizumab | Solution (Subcutaneous Injection) | Raptiva; anti alphaL integrin; antiCD11 alpha; hu1124; Raptiva (Genentech Inc) |
| Gengraf | dosage | Cyclosporine; Neoral; Restasis; Sandimmune; Cyclosporine (Abbott labs); Neoral (Novartis); Restasis (Allergan Inc); Sandimmune (Novartis) |
| Gengraf (Abbott labs) | dosage | Gengraf; Neoral; Restasis; Sandimmune; Cyclosporine; Neoral (Novartis); Restasis (Allergan Inc); Sandimmune (Novartis) |
| Humanized antiCD25 | dosage | Ig gamma-1 chain C region; Anti-IL-2; Daclizumab; Zenapax (Hoffmann-La Roche Inc) |
| Ig gamma-1 chain C region | dosage | Basiliximab; chimeric mouse-human antiCD25; Simulect (Novartis Pharmaceuticals) |
| Ig gamma-1 chain C region | dosage | Daclizumab; Anti-IL-2; Humanized antiCD25; Zenapax (Hoffmann-La Roche Inc) |
| Neoral | dosage | Gengraf; Cyclosporine; Restasis; Sandimmune; Gengraf (Abbott labs); Cyclosporine (Novartis); Restasis (Allergan Inc); Sandimmune (Novartis) |
| Neoral (Novartis) | dosage | Gengraf; Neoral; Restasis; Sandimmune; Gengraf (Abbott labs); Cyclosporine; Restasis (Allergan Inc); Sandimmune (Novartis) |
| Raptiva | dosage | Efalizumab; anti alphaL integrin; antiCD11 alpha; hu1124; Efalizumab (Genentech Inc) |
| Raptiva (Genentech Inc) | dosage | Raptiva; anti alphaL integrin; antiCD11 alpha; hu1124; Efalizumab |
| Restasis | dosage | Gengraf; Neoral; Cyclosporine; Sandimmune; Gengraf (Abbott labs); Neoral (Novartis); Cyclosporine (Allergan Inc); Sandimmune (Novartis) |
| Restasis (Allergan Inc) | dosage | Gengraf; Neoral; Restasis; Sandimmune; Gengraf (Abbott labs); Neoral (Novartis); Cyclosporine; Sandimmune (Novartis) |
| Sandimmune | dosage | Gengraf; Neoral; Restasis; Cyclosporine; Gengraf (Abbott labs); Neoral (Novartis); Restasis (Allergan Inc); Cyclosporine (Novartis) |
| Sandimmune (Novartis) | dosage | Gengraf; Neoral; Restasis; Sandimmune; Gengraf (Abbott labs); Neoral (Novartis); Restasis (Allergan Inc); Cyclosporine |
| Simulect (Novartis Pharmaceuticals) | dosage | Ig gamma-1 chain C region; chimeric mouse-human antiCD25; Basiliximab |
| Zenapax (Hoffmann-La Roche Inc) | dosage | Ig gamma-1 chain C region; Anti-IL-2; Humanized antiCD25; Daclizumab |
| anti alphaL integrin | dosage | Raptiva; Efalizumab; antiCD11 alpha; hu1124; Raptiva (Genentech Inc) |
| antiCD11 alpha | dosage | Raptiva; anti alphaL integrin; Efalizumab; hu1124; Raptiva (Genentech Inc) |
| chimeric mouse-human antiCD25 | dosage | Ig gamma-1 chain C region; Basiliximab; Simulect (Novartis Pharmaceuticals) |
| hu1124 | dosage | Raptiva; anti alphaL integrin; antiCD11 alpha; Efalizumab; Raptiva (Genentech Inc) |